SCHEMBL4957828

SCHEMBL4957828

CCOCOCCOC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23054396 0.97 ALDH1A1 (0.33)
SCHEMBL27995200 0.97 CA2 (0.34)
SCHEMBL28355209 0.94 ALDH1A1 (0.41)
SCHEMBL5694827 0.87 ALDH1A1 (0.42)
SCHEMBL1035786 0.87 CA2 (0.36)
SCHEMBL12228 0.84
SCHEMBL15384206 0.84 ALDH1A1 (0.40)
SCHEMBL14754921 0.84 CA2 (0.39)
SCHEMBL8766921 0.84 CA2 (0.39)
SCHEMBL6753265 0.84 ALDH1A1 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6277876-B1 Matrix metalloproteinase inhibitors LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2001-08-21 US claimed
CN-118522949-A Electrolyte based on trioxychain ether and application thereof 安徽工业大学 2024-08-20 CN disclosed
US-11857519-B2 Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide ARVINAS OPERATIONS, INC. (US) 2024-01-02 US disclosed
US-11348612-B2 E-iron oxide powder, composition including the same, magnetic recording medium, and magnetic recording and reproducing device FUJIFILM CORPORATION (JP) 2022-05-31 US disclosed
US-11170812-B2 Magnetic recording medium including specified compound, magnetic recording and reproducing apparatus, and composition for magnetic recording medium FUJIFILM CORPORATION (JP) 2021-11-09 US disclosed
US-20200312359-A1 E-IRON OXIDE POWDER, COMPOSITION INCLUDING THE SAME, MAGNETIC RECORDING MEDIUM, AND MAGNETIC RECORDING AND REPRODUCING DEVICE FUJIFILM CORPORATION (JP) 2020-10-01 US disclosed
US-20200075052-A1 MAGNETIC RECORDING MEDIUM, MAGNETIC RECORDING AND REPRODUCING APPARATUS, AND COMPOSITION FOR MAGNETIC RECORDING MEDIUM FUJIFILM CORPORATION (JP) 2020-03-05 US disclosed
US-20160171905-A1 MOBILE COMPUTING WEIGHT, DIET, NUTRITION, AND EXERCISE MANAGEMENT SYSTEM WITH ENHANCED FEEDBACK AND GOAL ACHIEVING FUNCTIONALITY SMARTEN LLC 2016-06-16 US disclosed
US-9310682-B2 Positive-type resist composition CENTRAL GLASS COMPANY, LIMITED (JP) 2016-04-12 US disclosed
US-9310682-B2 Positive-type resist composition CENTRAL GLASS COMPANY, LIMITED (JP) 2016-04-12 US disclosed
WO-2008151094-A1 METAL INKS, METHODS OF MAKING THE SAME, AND METHODS FOR PRINTING AND/OR FORMING METAL FILMS KOVIO, INC. (US) 2008-12-11 WO disclosed
US-20080023748-A1 Self-aligned contacts to source/drain regions PROMOS TECHNOLOGIES PTE. LTD. 2008-01-31 US disclosed
EP-1537124-B1 C-SUBSTITUTED TRICYCLIC ISOXAZOLINE DERIVATIVES AND THEIR USE AS ANTI-DEPRESSANTS JANSSEN PHARMACEUTICA NV (BE) 2007-08-01 EP disclosed
EP-1148072-A2 Fluoroelastomers Ausimont S.p.A. (IT) 2001-10-24 EP disclosed
US-5633243-A Anti-tumor platinum complexes, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1997-05-27 US disclosed
US-5527905-A RELATIVELY FEW SIDE EFFECTS, GOOD SOLUBILITY IN WATER SANKYO COMPANY, LIMITED (JP) 1996-06-18 US disclosed
EP-0290280-B1 Anti-tumor platinum complexes, their preparation and their therapeutic use SANKYO CO (JP) 1994-01-19 EP disclosed
EP-0388019-A1 Avermectin ketal derivatives useful as antiparasitic agents MERCK & CO. INC. (US) 1990-09-19 EP disclosed
EP-0290280-A2 Anti-tumor platinum complexes, their preparation and their therapeutic use Sankyo Company Limited (JP) 1988-11-09 EP disclosed
EP-0078235-A2 Dihalogenated steroids CIBA-GEIGY AG (CH) 1983-05-04 EP disclosed